--- title: What do we know about PMDD in autistic people and those with ADHD? description: Very little research exists on PMDD specifically in autistic people and those with ADHD. Early evidence suggests they may experience more severe symptoms and url: https://niyora.com/research/papers/mechanisms-and-clinical-care-gaps-in-pmdd-among-neurodivergent-people-2026/ --- - [Niyora](https://niyora.com/) - [Research](https://niyora.com/research/) - [Library](https://niyora.com/research/library/) - What do we know about PMDD in autistic people and those with ADHD? Systematic review, 2026 # What do we know about PMDD in autistic people and those with ADHD? Very little research exists on PMDD specifically in autistic people and those with ADHD. Early evidence suggests they may experience more severe symptoms and face barriers to diagnosis, but we cannot yet say for certain. Early or limited evidence Neurodivergent people assigned female at birth, particularly autistic individuals and those with ADHD ## What they did Scoping review (gathering and summarizing existing literature) on mechanisms and clinical care gaps for PMDD in neurodivergent people, particularly autistic individuals and those with ADHD. ## What they found Neurodivergent people may experience heightened sensory distress and worsening executive functioning during the menstrual cycle. Autistic adults report menstruation worsens sensory overload and emotional exhaustion. Proposed mechanisms include altered serotonin, heightened sensory sensitivity, hormone reactivity, stress dysregulation and executive dysfunction. Neurodivergent people remain underrepresented in reproductive health research. A major care gap exists: neurodivergent people often face diagnostic overshadowing, where PMDD symptoms are misattributed to autism or ADHD rather than recognized as hormone-related. ## What it means for you Neurodivergent people, especially autistic people and those with ADHD, may experience PMDD more severely than others, but evidence is too limited to confirm this or guide treatment. Healthcare providers often miss PMDD in these populations because they attribute symptoms to autism or ADHD instead of recognizing the menstrual connection. Much more research is urgently needed. 2 minimum menstrual cycles required for PMDD diagnosis ## About the study Original title Mechanisms and Clinical Care Gaps in PMDD Among Neurodivergent People, Particularly Autism and ADHD: A Scoping Review Authors Laila Faissal, Bridget Murray Year 2026 Study design Systematic review What was tested None (literature review) Open access Yes Read the paper [doi.org/10.17605/osf.io/3u7jx](https://doi.org/10.17605/osf.io/3u7jx) Original abstract Premenstrual dysphoric disorder (PMDD) is a severe cyclical mood disorder characterised by affective, cognitive and somatic symptoms that emerge during the luteal phase of the menstrual cycle and remit following menstruation (O'Brien et al., 2011). PMDD is formally recognised within the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) and differs from premenstrual syndrome (PMS) due to the severity of emotional distress and functional impairment associated with the condition. Symptoms commonly include affective instability, irritability, anxiety and impaired occupational or interpersonal functioning. The literature showed that neurodivergent individuals may also experience heightened sensory distress and worsening executive functioning during the menstrual cycle (Wynchank, 2025). Diagnosis requires prospective symptom confirmation across at least two menstrual cycles using validated instruments such as the Daily Record of Severity of Problems (DRSP) (American Psychiatric Association, 2013). Despite increasing recognition of PMDD within psychiatric and gynaecological research, limited evidence has examined how PMDD presents among neurodivergent populations, particularly autistic individuals and those with attention-deficit/hyperactivity disorder (ADHD). Emerging literature suggests that neurodivergent AFAB adults may experience heightened menstrual-related distress, emotional dysregulation, sensory difficulties and worsening executive-function impairment across the menstrual cycle (Steward et al., 2018). Research involving autistic adults has demonstrated that menstruation may exacerbate sensory overload, emotional exhaustion and difficulties with daily functioning (Young et al., 2018). Proposed mechanisms linking PMDD with neurodivergence include altered serotonergic functioning, heightened sensory processing sensitivity, hormonal reactivity, stress dysregulation and executive dysfunction (Kornstein & Pearlstein, 2021). However, current evidence remains dispersed across psychiatry, neurodevelopmental, reproductive health and women’s health literature. Neurodivergent individuals have historically been underrepresented in reproductive mental health research, contributing to limited understanding of PMDD symptom profiles, treatment response and healthcare needs within these populations (Halladay et al., 2015). Clinical care gaps also appear substantial. Neurodivergent AFAB adults may experience diagnostic overshadowing, where cyclical PMDD symptoms are attributed solely to autism or ADHD rather than recognised as hormone-related distress (Steward et al., 2018). Difficulties accessing gynaecological care, limited clinician awareness of neurodivergent presentations, communication barriers and the absence of neurodiversity-adapted interventions may further contribute to delayed diagnosis and unmet treatment needs. Given the emerging and heterogeneous nature of this evidence base, a scoping review is considered the most appropriate methodology to systematically map existing evidence, identify conceptual trends, summarise proposed mechanisms and care-related findings and highlight gaps requiring future investigation (Arksey & O’Malley, 2005; Peters et al., 2020). The review will follow the Joanna Briggs Institute (JBI) methodology for scoping reviews and will be reported according to the PRISMA extension for Scoping Reviews (PRISMA-ScR) guidelines (Tricco et al., 2018). Reproduced under CC-BY. ## Topics [Premenstrual syndrome (PMS)](https://niyora.com/research/topics/condition-pms/)[Premenstrual dysphoric disorder (PMDD)](https://niyora.com/research/topics/condition-pmdd/)[Menstrual cycle and mood](https://niyora.com/research/topics/condition-cycle-mood/)[Mood swings and emotion regulation](https://niyora.com/research/topics/symptom-emotional-regulation/)[Cognition, concentration and memory](https://niyora.com/research/topics/symptom-cognition/)[ADHD](https://niyora.com/research/topics/comorbidity-adhd/)[Autism](https://niyora.com/research/topics/comorbidity-autism/)[Work and productivity](https://niyora.com/research/topics/life-area-work/)[Quality of life and daily functioning](https://niyora.com/research/topics/life-area-quality-of-life/) Research tells you what helps on average. Niyora helps on the day it hits. Calm down, see it another way, and decide what to say, with a PMS and PMDD app built by a doctor. ## Related studies Randomised trial, 2023 What does research show about PMDD neurochemistry? Survey study, 2026 Are PMS and PMDD the same condition or are they different? Survey study, 2026 Do women with ADHD and autism have more premenstrual problems than women without these conditions? Review, 2026 How does the menstrual cycle affect concentration and work productivity? Review, 2025 How does the menstrual cycle affect ADHD symptoms and concentration? Cohort study, 2023 Are PMS symptoms linked to genetic factors for psychiatric disorders? Ask AI about this page Copy prompt ChatGPT ↗ Claude ↗ Perplexity ↗ Google AI Mode ↗ Grok ↗